Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with multinational pharmaceutical company Lupin Limited and the COPD Foundation to expand access to Tiotropium Bromide Inhalation Powder for chronic obstructive pulmonary disease patients in the U.S.
COPD is a chronic inflammatory lung disease that obstructs airflow from the lungs and causes breathing problems. Tiotropium Bromide treats...
E-pharmacy MrMed scores half mil for expansion
Online pharmacy MrMed has raised $500,000 from a funding round led by the Tamil Nadu Emerging Sector Seed Fund.
According to a news report, the company will use its fresh funds to expand its team and reach out to more customers.
Launched in 2021, the pharmacy startup offers specialty medicines for cancer, heart disorders, and other critical health...
California-based AI drug discovery startup Genesis announced it scored a whopping $200 million in an oversubscribed Series B funding round, bringing its total raise to $280 million.
The company also announced that approximately $24 million of SAFE notes from a prior funding round were converted amid the closing of the Series B round.
Andreessen Horowitz and a "U.S.-based life sciences-focused...
Global clinical technology company Wolters Kluwer Health and health tech company Unbound Medicine announced the launch of a mobile app version of Lippincott’s Nursing Drug Handbook, a pocket drug guide for nurses.
The app, which brings the print edition of Lippincott's handbook to the digital space, will include latest updates from the FDA and data on more than 3,800 generic, brand name and...
Causaly, a tech company using AI to interpret large datasets and literature, announced it closed a $60 million Series B round led by ICONIQ Growth.
Marathon Venture Capital, Index Ventures, Pentech Ventures, EBRD and Visionaries Club also participated in the round, as did former chairman and CEO of Johnson & Johnson Alex Gorsky and CEO and cofounder of Datadog Olivier Pomel.
WHAT IT DOES...
CVS Caremark, a pharmacy benefit manager and part of CVS Health, announced it is partnering with drug cost and telehealth company GoodRx to launch Caremark Cost Saver, providing Caremark's members access to GoodRx's lower-cost prescription pricing.
Beginning January 1, 2024, Caremark's members can use their existing benefit card at an in-network pharmacy of their choice to automatically have...
Mark Cuban Cost Plus Drug Company (MCCPDC) has announced a partnership with male fertility and sexual healthcare company Posterity Health to provide males access to medications to treat infertility, sexual dysfunction and low testosterone.
Posterity Health is a digital male fertility clinic providing access to reproductive urologists who diagnose and treat sexual health and male fertility issues...
Mark Cuban Cost Plus Drug Company (MCCPDC) announced that it's working with Coherus Biosciences to sell Yusimry, a biosimilar version of the top-selling drug Humira, at a discounted price.
Yusimry is used to treat several diseases, such as rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, ulcerative colitis, hidradenitis suppurativa, Crohn’s...
Tricog snaps up $9M funding for US expansion
AI-based cardiac diagnosis solution provider Tricog has raised Rs 700 million ($8.5 million) in a Series B2 funding round led by Japanese institutions, Omron and Sony Innovation Fund. The round was also participated by the University of Tokyo Edge Capital, Inventus Partners, and Singapore's SG Innovate.
The startup plans to use its fresh funds for its...
Drug cost and telehealth platform GoodRx has appointed previous GoDaddy leader Scott Wagner as interim chief executive officer, replacing cofounders and co-CEOs Doug Hirsch and Trevor Bezdek.
Hirsch and Bezdek will remain within GoodRx's leadership team, with Hirsch acting as chief mission officer and Bezdek as chairman.
Hirsch will work with the company's community of healthcare providers and...
_1.jpg?itok=TSQSsVDE "Mark Cuban, cofounder of Mark Cuban Cost Plus Drug Company")
_3.jpg?itok=ONMvEXvl "Scott Wagner, interim chief executive officer of GoodRx")
